Legal Opinion
Amgen, Inc. v. Hoechst Marion Roussel, Inc.
District Court, D. Massachusetts
Decided October 15, 2004No. CIV.A. 97-10814-WGYPublishedCited by 11 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
YOUNG, Chief Judge.
I. INTRODUCTION
This patent infringement action concerns patents held by Amgen, Inc. (“Am-gen”), relating to the manufacture of a recombinant (genetically engineered) DNA 1 product, known as epoietin alfa, 2 that is similar to natural erythropoietin (“EPO”), a hormone that stimulates production of red blood cells, and is useful in, among other things, treating patients who need blood transfusions and suffer from blood composition disorders such as hemophilia, anemia, and sickle cell disease. This product and this case are not new to the public or to this…
2Cases cited165 opinions
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
160 more not listed; retrieve them via the Exa API.
3Cited by11 opinions
- Amgen v. Hoechst Marion Roussel (Now Known as Aventis Pharmaceuticals)Court of Appeals for the Federal Circuit · 2006
- In Re SarafoglouUnited States Bankruptcy Court, D. Massachusetts · 2006
- Amgen, Inc. v. F. Hoffmann-La Roche Ltd.District Court, D. Massachusetts · 2008
- EBS Dealing Resources, Inc. v. Intercontinental Exchange, Inc.District Court, S.D. New York · 2005
- Amgen Inc. v. Hoechst Marion Roussel, Inc.District Court, D. Massachusetts · 2008
6 more not listed; retrieve them via the Exa API.